Skip to main content
. 2018 Sep 14;10(9):1304. doi: 10.3390/nu10091304

Figure 3.

Figure 3

Cell viability in function of the concentration of nutraceutical-loaded uncoated and chitosan-coated nanoemulsions all tested at concentrations from 0.5 to 5% v/v of oil tested combined with doxorubicin at 20 µM. (A). The viability of cardiomyoblasts incubated with doxorubicin (at 20 µM) in association with Enalapril at 10, 25 and 50 µM and Carvedilol at 1, 5 and 10 µM. (B). Difference in the percentage of cell viability versus control cells, between (C) Enalapril and (D) Carvedilol and the best nanoemulsion (dryTom-Ne-CT) at different concentrations * p < 0.001; ** p < 0.05; ns: not significant.